FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Bioness Receives CE Mark for Neuromodulation System

Feb. 20, 2019
A A

Valencia, California devicemaker Bioness earned the CE Mark for its StimRouter neuromodulation device.

The system is now cleared in Europe for treating overactive bladder, a condition that impacts the quality of life of nearly half a billion people worldwide.

The product serves as a permanent solution for overactive bladder. It involves implantation of a small wire and a wearable patch over the implant that lets patients control their symptoms through gentle stimulating pulses.

View today's stories